These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 28671303

  • 1. Increased complement activation during platelet storage.
    Chen J, Losos M, Yang S, Li J, Wu H, Cataland S.
    Transfusion; 2017 Sep; 57(9):2182-2188. PubMed ID: 28671303
    [Abstract] [Full Text] [Related]

  • 2. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
    Gyongyossy-Issa MI, McLeod E, Devine DV.
    J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
    [Abstract] [Full Text] [Related]

  • 3. Platelet concentrates in platelet additive solutions generate less complement activation products during storage than platelets stored in plasma.
    de Wit YES, Vlaar R, Gouwerok E, Hamzeh-Cognasse H, van Mierlo G, Bulder I, Lagerberg JWM, de Korte D, Cognasse F, Ten Brinke A, Zeerleder SS.
    Blood Transfus; 2023 Mar; 21(2):157-167. PubMed ID: 35302481
    [Abstract] [Full Text] [Related]

  • 4. Effect of blood sampling, processing, and storage on the measurement of complement activation biomarkers.
    Yang S, McGookey M, Wang Y, Cataland SR, Wu HM.
    Am J Clin Pathol; 2015 Apr; 143(4):558-65. PubMed ID: 25780008
    [Abstract] [Full Text] [Related]

  • 5. Complement activation during storage of single-donor platelet concentrates.
    Schleuning M, Böck M, Mempel W.
    Vox Sang; 1994 Apr; 67(2):144-8. PubMed ID: 7801603
    [Abstract] [Full Text] [Related]

  • 6. Prolonged platelet storage associated with increased frequency of transfusion-related adverse events.
    Losos M, Biller E, Li J, Blower L, Hamad D, Patel G, Scrape S, Cataland S, Chen J.
    Vox Sang; 2018 Feb; 113(2):170-176. PubMed ID: 29243264
    [Abstract] [Full Text] [Related]

  • 7. The influence of platelet additive solutions on cytokine levels and complement activation in platelet concentrates during storage.
    Cardigan R, Sutherland J, Wadhwa M, Dilger P, Thorpe R.
    Vox Sang; 2003 Jan; 84(1):28-35. PubMed ID: 12542731
    [Abstract] [Full Text] [Related]

  • 8. Plasmin activity and complement activation during storage of citrated platelet concentrates.
    Bode AP, Miller DT, Newman SL, Castellani WJ, Norris HT.
    J Lab Clin Med; 1989 Jan; 113(1):94-102. PubMed ID: 2521240
    [Abstract] [Full Text] [Related]

  • 9. Complement activation in prestorage leucocyte-filtered plasma.
    Hyllner M, Tylman M, Bengtson JP, Rydberg L, Bengtsson A.
    Transfus Med; 2004 Feb; 14(1):45-52. PubMed ID: 15043593
    [Abstract] [Full Text] [Related]

  • 10. Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasma.
    Norda R, Schött U, Berséus O, Akerblom O, Nilsson B, Ekdahl KN, Stegmayr BG, Knutson F.
    Vox Sang; 2012 Feb; 102(2):125-33. PubMed ID: 21770955
    [Abstract] [Full Text] [Related]

  • 11. DAMPS and complement activation in platelet concentrates that induce adverse reactions in patients.
    de Wit YES, Hamzeh-Cognasse H, Cognasse F, Ten Brinke A, Zeerleder SS.
    Transfusion; 2022 Sep; 62(9):1721-1726. PubMed ID: 35950480
    [Abstract] [Full Text] [Related]

  • 12. Benefit of prestorage leukocyte depletion of single-donor platelet concentrates.
    Chalandon Y, Mermillod B, Beris P, Doucet A, Chapuis B, Roux-Lombard P, Dayer JM.
    Vox Sang; 1999 Sep; 76(1):27-37. PubMed ID: 9933851
    [Abstract] [Full Text] [Related]

  • 13. Blood platelets activate the classical pathway of human complement.
    Peerschke EI, Yin W, Grigg SE, Ghebrehiwet B.
    J Thromb Haemost; 2006 Sep; 4(9):2035-42. PubMed ID: 16961611
    [Abstract] [Full Text] [Related]

  • 14. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.
    Rinder CS, Rinder HM, Smith BR, Fitch JC, Smith MJ, Tracey JB, Matis LA, Squinto SP, Rollins SA.
    J Clin Invest; 1995 Sep; 96(3):1564-72. PubMed ID: 7657827
    [Abstract] [Full Text] [Related]

  • 15. Removal by adsorbent beads of biological response modifiers released from platelets, accumulated during storage, and potentially associated with platelet transfusion reactions.
    Tanaka S, Hayashi T, Tani Y, Hirayama F.
    Transfusion; 2010 May; 50(5):1096-105. PubMed ID: 20051054
    [Abstract] [Full Text] [Related]

  • 16. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
    Ogawa Y, Wakana M, Tanaka K, Oka K, Aso H, Hayashi M, Seno T, Ishida T, Nomura S, Fukuhara S.
    Vox Sang; 1998 May; 75(2):103-9. PubMed ID: 9784662
    [Abstract] [Full Text] [Related]

  • 17. Immunomodulatory mediators in platelet transfusion reactions.
    Morrell CN.
    Hematology Am Soc Hematol Educ Program; 2011 May; 2011():470-4. PubMed ID: 22160076
    [Abstract] [Full Text] [Related]

  • 18. Septic risk increases with apheresis platelet storage time.
    Wagner SJ, Dy B, Young P, Goldberg C, Mair D, Fadeyi E, Poisson J, Cohn C.
    Transfusion; 2020 Jan; 60(1):220-222. PubMed ID: 31898352
    [No Abstract] [Full Text] [Related]

  • 19. Nitric oxide infusion alleviates cellular activation during preparation, leukofiltration and storage of platelets.
    Wong K, Li X.
    Transfus Apher Sci; 2004 Feb; 30(1):29-39. PubMed ID: 14746819
    [Abstract] [Full Text] [Related]

  • 20. Membrane attack complex generation increases as a function of time in stored blood.
    Hu X, Patel RP, Weinberg JA, Marques MB, Ramos TN, Barnum SR.
    Transfus Med; 2014 Apr; 24(2):114-6. PubMed ID: 24588971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.